Skip to content
OpenCapital
Get started

Allogene Therapeutics ALLO Cash ratio

Cash ratio at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
0.5×0.0×
Gilead Sciences logo
Gilead SciencesGILD
0.8×+0.2×
Precigen logo
PrecigenPGEN
0.4×+0.1×
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
3.1×+1.1×
Sana Biotechnology logo
Sana BiotechnologySANA
1×-1.9×
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
0.8×-0.1×

Other financials

Income statement

See full
Revenue-—
Operating income-$46.1M+29.3%
Net income-$42.6M+28.7%
EPS (diluted)-$0.18+35.7%

Balance sheet

See full
Cash & equivalents$40.6M-23.0%
Total debt$81.1M-8.9%
Total equity$278.9M-27.6%
Total assets$396.0M-22.1%

Cash flow

See full
Operating cash flow-$12.9M+75.6%
CapEx$9.0K-90.9%
Free cash flow-$12.9M+75.6%

Valuation

See full
Market cap$711.02M+164%
Enterprise value$751.47M+146%

Profitability

See full
Operating margin-1,241,813.6%-2,018,140pp
Net margin-1,170,863.6%-2,007,890pp
FCF margin-913,609.1%-1,474,890pp

Returns & leverage

See full
Return on equity-52.3%-5.7pp
Debt / equity0.3×+0.1×
Current ratio9.6×-0.1×

Where this comes from

Calculated from Allogene Therapeutics’s reported figures.

cash and equivalents/total current liabilities=1.4×

Based on the most recent quarter.

The official record: Allogene Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Allogene Therapeutics's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Allogene Therapeutics's cash ratio?
Allogene Therapeutics (ALLO) reported cash ratio of 1.4× in Q1 2026.
How has Allogene Therapeutics's cash ratio changed year-over-year?
Allogene Therapeutics's cash ratio decreased by 18.4% year-over-year, from 1.8× to 1.4×.
What is the long-term trend for Allogene Therapeutics's cash ratio?
Over 5 years (2020 to 2025), Allogene Therapeutics's cash ratio has grown at a -1.4% compound annual growth rate (CAGR), from 2× to 1.9×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.